Wed, December 6, 2023
Tue, December 5, 2023
Mon, December 4, 2023

Olivia Brayer Reiterated (VRTX) at Buy and Held Target at $380 on, Dec 5th, 2023

Olivia Brayer of Cantor Fitzgerald, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $380 on, Dec 5th, 2023.

Olivia has made no other calls on VRTX in the last 4 months.



There are 8 other peers that have a rating on VRTX. Out of the 8 peers that are also analyzing VRTX, 4 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Reiterated at Hold and Held Target at $373 on, Wednesday, November 22nd, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $364 on, Wednesday, November 8th, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $347 on, Tuesday, November 7th, 2023
  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Increased Target to $315 on, Monday, August 7th, 2023


These are the ratings of the 4 analyists that currently disagree with Olivia


  • Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $415 on, Tuesday, November 7th, 2023
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $390 on, Tuesday, November 7th, 2023
  • Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $370 on, Tuesday, October 17th, 2023
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $456 on, Wednesday, October 4th, 2023